Monophosphoryl lipid A induces delayed preconditioning against cardiac ischemia-reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 1, 1998, Pages 3-17

  Elliott, Gary T ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHORYL LIPID A; POTASSIUM CHANNEL;

AORTA VALVE REPLACEMENT; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOG; DRUG EFFICACY; ENZYME ACTIVATION; HEART ARRHYTHMIA; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; REVIEW; STUNNED HEART MUSCLE;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

EID: 0031940890     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0586     Document Type: Article

References (110)

1. ABD-ELFATTAH AS, GUO J, EL-SIGABY NR, ELLIOTT GT, SHEBAB MI, 1995. Intravenous administration of monophosphoryl lipid A (MLA) 24 hours before aortic cross-clamping attenuates myocardial stunning in dogs. J Mol Cell Cardiol 27: A49.
2. AGUGGINI G, HUSSAIN SNA, VANELLI G, 1995. Glibenclamide, a blocker of ATP-sensitive potassium channels, reverses endotoxin-induced hypotension in the pig. Exp Physiol 80: 167-170.
3. ANDRIANTSITOHAINA R, LAGAUD GJ, ANDRE A, MULLER B, STOCKLET JC, 1995. Effects of cGMP on calcium handling in ATP-stimulated rat resistance arteries. Am J Physiol 268: H1223-H1231.
4. ATP channels. Eur J Pharmacol 313: 229-235.
5. ASTIZ ME, RACKOW EC, STILL JG, HOWELL ST, CATO A, VON ESCHEN KB, ULRICH JT, RUDBACH JA, MCMAHON G, VARGAS R, STERN W, 1995. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: A prospective, double blind, randomized trial. Crit Care Med 23: 9-17.
6. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 264: H1327-H1336.
7. BAXTER GF, MARBER MS, PATEL VC, YELLON DM, 1994. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000.
8. BAXTER GF, GOODWIN RW, WRIGHT MJ, KERAC M, HEADS RJ, YELLON DM, 1996. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Brit J Pharmacol 117: 1685-1692.
9. BERG JT, ALLISON RC, TAYLOR AE, 1990. Endotoxin extends survival of adult mice in hyperoxia. Proc Soc Exp Biol Med 193: 167-170.
10. BLEBEA J, BACIK B, STROTHMAN G, MYATT L, 1996. Decreased nitric oxide production following extremity ischemia and reperfusion. Am J Surg 172: 158-161.
11. BOLLI R, HARTLEY CJ, CHELLY JE, PATEL BS, RABINOVITZ RS, JEROUDI MO, ROBERTS R, NOON G, 1990. An accurate, nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery. J Am Coll Cardiol 15: 1055-1065.
12. BROWN JM, GROSSO MA, TERADA LS, WHITMAN GJR, BANERJEE A, WHITE CW, HARKEN AH, REPIN JE, 1989. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemic-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci USA 86: 2516-2620.
13. BUGGE E, YTREHUS K, 1995. Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischaemic preconditioning. Cardiovasc Res 29: 269-274.
14. CAMERON JS, KIBLER KKA, BERRY H, BARRON DN, SODDER VH, 1996. Nitric oxide activates ATP-sensitive potassium channels in hypertrophied ventricular myocytes. FASEB J 10: A65.
15. 31P NMR study in the isolated rat heart. Am J Physiol Heart Circ Physiol 272: H544-H552.
16. CHEN W, WETSEL W, STEENBERGEN C, MURPHY E, 1996. Effect of ischemia preconditioning and PKC activation on acidification during ischemia in rat heart. J Mol Cell Cardiol 28: 871-880.
17. 1 receptor activation. J Mol Cell Cardiol 29: A67.
18. 2+, intercellular electrical coupling and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ Res 79: 237-246.
19. DOWNEY JM, COHEN MV, 1995. Signal transduction in ischemic preconditioning. Z Kardiol 84 (Suppl. 4): 77-86.
20. EGDELL RM, SIMINIAK T, SHERIDAN DJ, 1994. Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol 89: 499-509.
21. ELLIOTT GT, COMERFORD ML, SMITH JR, ZHAO L, 1996. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide. Cardiovasc Res 32: 1071-1080.
22. FEHER JJ, LEBOLT WR, MANSON NH, 1989. Differential effect of global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ Res 65: 1400-1408.
23. 1 cells. Am J Physiol Cell Physiol 272: C737-C743.
24. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76: 1036-1048.
25. GATO M, LUI Y, YANG X-M, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
26. GOTTLIEB RA, GRUOL DL, ZHU JY ENGLER RL, 1996. Preconditioning in rabbit cardiomyocytes - role of pH, vacuolar proton ATPase and apoptosis. J Clin Invest 97: 2391-2398.
27. GREAVES SC, RUTHERFORD JD, ARANKI SF, COHN LH, COUPER GS, ADAMS DH, RIZZO RJ, COLLINS JJ, JR, ANTMAN EM, 1996. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J 132: 572-578.
28. GROSS GJ, MEI DA, SCHULTZ JJ, MIZUMURA T, 1996. Criteria for a mediator or effector of myocardial preconditioning: do KATP channels meet the requirement. Basic Res Cardiol 91: 31-34.
29. ATP channel. J Mol Cell Cardiol 29: A229.
30. GUSTAFSON GL, RHODES MJ, HEGEL T, 1995. Monophosphoryl lipid A as a prophylactic for sepsis and septic shock. Prog Clin Biol Res 392: 567-579.
31. HE GW, ACUFF TE, RYAN WH, BOWMAN RT, DOUTHIT MB, MACK MJ, 1994. Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. Emphasis on the influence of internal mammary artery grafting on mortality and morbidity. Thorac Cardiovasc Surg 108: 73-81.
32. IRIE H, 1988. Experimental studies on ischemic injury and reperfusion injury to the cardiac sarcoplasmic reticulum. Jap Circulation J 52: 563-569.
33. JAGASIA D, WHITING JM, MCNULTY PH, 1996. Ischemic preconditioning fails to produce a second window of protection 24hrs later in the rat. Circulation 94 (Suppl. 1): I-184.
34. ATP channel. Cardiovasc Res (In press).
35. JOHNSON G, TSAO PS, LEFLER AM, 1991. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19: 244-252.
36. KANNON MS, PRAKASH YS, JOHNSON DE, SIECK GC, 1997. Nitric oxide inhibits calcium release from sarcoplasmic reticulum of porcine tracheal smooth muscle cells. Am J Physiol 272 (1PT1): L1-L7.
37. KAPLAN P, HENDRIKX M, MATTHEUSSEN M, MUBAGWA K, FLAMENG W, 1992. Effect of ischemia and reperfusion on sarcoplasmic reticulum calcium uptake. Circ Res 71: 1123-1130.
38. + exchange inhibitors against cardiac injury produced by ischemia/reperfusion, hypoxia/reoxygenation, and the calcium paradox. J Cardiovasc Pharmacol 21: 172-178.
39. KITAKAZE M, HORI M, TAKASHIMA S, SATO H, INOUE M, KAMADA T, 1993. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Circulation 87: 208-215.
40. KITAKAZE M, HORI M, MORIOKA T, MINAMINO Y, TAKASHIMA S, SATO H, SHINOZAKI Y CHUJO M, MORI H, INOUE M, KAMADA T, 1994. Infarct size limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246.
41. 2+-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol 25: 163-167.
42. KLOBUSICKA M, KUSENDA J, 1992. Cytochemical study of activated peritoneal macrophages in normal and tumor-bearing rats. Neoplasma 39: 291-297.
43. KONG L-Y, MCMILLIAN MK, MARONPORT R, HONG J-S, 1996. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microgliaenriched or astrocyte-enriched cultures. Brain Res 729: 102-109.
44. KUKREJA RC, JANIN Y, 1997. Reperfusion injury: basic concepts and protection strategies. J Thrombosis Thrombolysis 4: 7-24.
45. KUKREJA RC, WEAVER AB, HESS ML, 1989. Stimulated human neutrophils damage cardiac sarcoplasmic reticulum function by generation of oxidants. Biochem Biophys Acta 990: 198-205.
46. 2+-ATP-ase of cardiac sarcoplasmic reticulum. Circ Res 69: 1003-1014.
47. LAZAR HL, FITZGERALD C, GROSS S, HEEREN T, ALDEA GS, SHERMIN RJ, 1995. Determinants of length of stay after coronary artery bypass graft surgery. Circulation 92 (Suppl. 9): II20-II24.
48. LEE BS, KANG HS, PYUN KH, CHOI I, 1997. Roles of tyrosine kinases in the regulation of nitric oxide synthase in murine liver cells: modulation of NF-kappa B activity by tyrosine kinase. Hepatology 25: 913-919.
49. LEFER DJ, NAKANISHI K, JOHNSTON WE, VINTEN-JOHANSEN J, 1993. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350.
50. + currents by protein kinase C and adenosine: implications for ischemic preconditioning. Circ Res 78: 443-454.
51. MANGANO DT, 1997. Effects of acadesine on myocardial infarction, stroke and death following surgery. JAMA 277: 325-332.
52. MARBER MS, LATCHMAN DS, WALKER JM, YELLON DM, 1993. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272.
53. MAULIK N, ENGELMAN DT, WATANABE M, ENGELMAN RM, MAULIK G, CORDIS GA, DAS DK, 1995. Nitric oxide signaling in ischemic heart. Cardiovasc Res 30: 593-601.
54. MAULIK N, ENGELMAN DT, WATANABE M, ENGELMAN RM, DAS DK, 1996a. Nitric oxide - a retrograde messenger for carbon monoxide signaling in ischemic heart. Mol Cell Biochem 157: 75-86.
55. MAULIK N, ENGELMAN DT, WATANABE M, ENGELMAN RM, ROUSOU JA, FLACK JE, DEATON DW, GORBUNOV NV, ELSAYED NM, KAGON VE, DAS DK, 1996b. Nitric oxide carbon monoxide - a molecular switch for myocardial preservation during ischemia. Circulation 94: II-3 98-II-406.
56. MAULIK N, WATANABE M, ZU YL, HUANG CK, CORDIS GA, SCHLEY JA, FAS DK, 1996c. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237.
57. MAULIK N, TOSAKI A, ELLIOTT GT, MAULIK G, DAS DK, 1997. Induction if iNOS expression by monophosphoryl lipid A: a pharmacological approach for myocardial adaptation to ischemia. Int J Tissue Reactions 19: 35.
58. MAZER DC, 1993. Calcium and stunned myocardium. J Card Surg 8: 329-331.
59. MCKENNA TM, LI S, TAO S, 1995. PKC mediates LPS and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 269 (Heart Circ Physiol 38): H1891-H1898.
60. ATP channels mediate the infarct reducing effect of late preconditioning produced by monophosphoryl lipid A. Am J Physiol 271 (Heart Circ Physiol 40): H2723-H2729.
61. MEI DA, ELLIOTT GT, GROSS GJ, 1996b. Comparative effects of early ischemic preconditioning (PC) and late PC produced by monophosphoryl lipid A upon myocardial infarct size and interstitial purine metabolism in dogs. Circulation 94 (Suppl. I): I-185.
62. + channel of vascular smooth muscle cells. FEBS Lett 345: 47-49.
63. MIZUMURA T, NITHIPATIKOM K, GROSS GJ, 1995. Bimikalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release and neutrophil function in dogs. Circulation 92: 1236-1245.
64. MUBAGWA K, 1995. Sarcoplasmic reticulum function during myocardial ischaemia and reperfusion. Cardiovasc Res 30: 166-175.
65. MURRAY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
66. MURRAY CE, RICHARD VJ, REIMER KA, JENNINGS RB, 1990. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931.
67. MURRAY CE, RICHARD VJ, JENNINGS RB, REIMER KA, 1991. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260: H796-H804.
68. MYERS KR, TRUCHOT AT, WARD J, HUDSON Y, ULRICH JT, 1990. A critical determinant of lipid A endotoxic activity. In: Nowotny A, Spitzer J and Ziegler E (eds). Cellular and Molecular Aspects of Endotoxin Reactions. Amsterdam: Elsevier, 145-156.
69. NAKANISHI K, VINTEN-JOHANSEN J, LEFER DJ, ZHAO Z, FOWLER III WC, MCGEE DS, JOHNSTON WE, 1992. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol 263: H1650-H1658.
70. NAUNHEIM KS, FIORE AS, WADLEY JJ, MCBRIDE LR, KANTER KR, PENNINGTON DG, BARNER HB, KAISER GC, WILLMAN VL, 1988. The changing profile of the patient undergoing coronary artery bypass surgery. J Am Coll Cardiol 11: 494-498.
71. ATP channel. J Mol Cell Cardiol 29: A231.
72. NAYEEM MA, ELLIOTT GT, SHAH MR, HASTILLO-HESS SL, KUKREJA RC, 1997b. Monophosphoryl lipid A protects adult rat cardiomyocytes with specific induction of the 72-KD heat shock protein. J Mol Cell Cardiol 29: 2305-2310.
73. NELSON SK, WONG GHW, MCCORD JM, 1995. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol 27: 223-229.
74. PAN J, BURGHER KL, SZCZEPANIK AM, RINGHEIM GE, 1996. Tyrosine phosphorylation of inducible nitric oxide synthase: implications for potential post-translational regulation. Biochem J 314: 889-894.
75. PARRATT J, VEGH A, 1994. Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 1: 9-18.
76. PIACENTINI L, WAINWRIGHT CL, PARRATT KR, 1993. The antiarrhythmic effect of ischemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res 27: 674-680.
77. PRZYKLENK K, HATA K, ZHAO L, KLONER RA, ELLIOTT GT, 1996a. Preconditioning does not depend upon enhanced 5′-nucleotidase activity or increased adenosine levels during sustained coronary occlusion. Circulation 94 (Suppl. I): I-550.
78. PRZYKLENK K, ZHAO L, KLONER RA, ELLIOTT GT, 1996b. Cardioprotection with ischemic preconditioning and monophosphoryl lipid A: role of adenosine regulating enzymes? Am J Physiol 271 (Heart Circ Physiol 40): H1004-H1014.
79. PRZYKLENK K, HATA K, ZHAO L, KLONER RA, ELLIOTT GT, 1997. Disparate effects of preconditioning and MLA on 5′ nucleotidase and adenosine levels during coronary occlusion. Am J Physiol 273 (Heart Circ Physiol 42): H945-H951.
80. QIU Y, TANG XL, PARK SW, SUN JZ, KALYA A, BOLLI R, 1997. The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res 80: 730-742.
81. RIBI E, 1984. Beneficial modification of the endotoxin molecule. J Biol Response Modif 3: 1-9.
82. SHINDO T, IKEDA U, OHKAWA F, KAWAHARA Y, YOKOYAMA M, SHIMADA K, 1995. Nitric oxide synthesis in cardiac myocytes and flbroblasts by inflammatory cytokines. Cardiovasc Res 29: 813-819.
83. SIMMONS ML, MURPHY S, 1994. Roles for protein kinase in the induction of nitric oxide synthase in astrocytes. GLIA 11: 227-234.
84. SMITH GB, STENFENELLI T, WU ST, WIKMAN-COEFELT J, PARMLEY WW, ZAUGG CE, 1996. Rapid adaptation of myocardial calcium homeostasis to short episodes of ischemia in isolated rat hearts. Am Heart J 131: 1106-1112.
85. SUN JZ, TANG XL, PARK SW, QIU Y, TURRENS JF, BOLLI R, 1996. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 15: 562-576.
86. TANAKA M, FUJIWARA H, YAMUSAKI K, MIYAMAE M, YOKOTA R, HASEGAWA K, FUJIWARA T, SASAYAMA S, 1994. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 hours later in rabbits. Am J Physiol 267: H1476-H1482.
87. 1-selective adenosine analogues protect the heart against infarction. Circulation 85: 659-665.
88. THORNTON JD, DALY JF, COHEN MV, YANG X-M, DOWNEY JM, 1993. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 73: 649-655.
89. ATP channel by oxygen free radicals produced by xanthine oxidase reaction. Am J Physiol 271 (Heart Circ Physiol 40): H478-H489.
90. TOMASOVIC SP, KLOSTERGAARD J, 1991. Bacterial endotoxin lipopolysaccharide modulates synthesis of the 70 kDa heat stress protein family. Int J Hyperthermia 7: 643-651.
91. ULRICH JT, MYERS KR, 1995. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm Biotechnol 6: 495-524.
92. VAN BENTHUYSEN KM, MCMURTRY IF, HORWITZ LD, 1987. Reperfusion after acute coronary occlusion in dogs impares endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in-vitro. J Clin Invest 79: 265-274.
93. VAN WINKLE DM, THORNTON JB, DOWNEY DM, DOWNEY JM, 1991. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coronary Art Dis 2: 681-689.
94. VEGH A, PAPP JG, PARRATT JR, 1994. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20h after rapid cardiac pacing. Br J Pharmacol 113: 1081-1082.
95. VEGH A, PAPP JG, ELLIOTT GT, PARRATT JR, 1996. Pretreatment with monophosphoryl lipid A (MPL®-C) reduces ischaemia reperfusion-induced arrhythmias in dogs. J Mol Cell Cardiol 28: A56.
96. VISNER GA, DOUGALL WC, WILSON JM, BURR IA, NICK HS, 1990. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. J Biol Chem 265: 2856-2864.
97. ATP channels in the mechanism of cardioprotective ischemic preconditioning. Circulation 92 (Suppl. I): I-252.
98. WEBER PA, SMART M, COMERFORD ML, SMITH J, ZHAO L, ELLIOTT GT, 1997a. Monophosphoryl lipid A mimics both the first and second window of ischemic preconditioning and preserves myocardial sarcoplasmic reticular calcium pump. J Mol Cell Cardiol 94: A71.
99. WEBER PA, SMART M, COMERFORD ML, SMITH J, ZHAO L, ELLIOTT GT, 1997b. Monophosphoryl lipid A pretreatment preserves sarcoplasmic reticulum (SR) calcium uptake in the face of cardiac ischemia reperfusion injury in the rabbit. Eur Heart J 18 (Abstract Suppl.): 44.
100. WEYRICH AS, MA X, LEFER AM, 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288.
101. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 80: 76-81.
102. YAMASHITA N, NISHIDA M, HOSHIDA S, KUZUVA T, HORI M, TANIGUCHI N, KANADA T, TADA M, 1994. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 94: 2193-2199.
103. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res 73: 1193-1201.
104. YAO Z, AUCHAMPACH JA, PIEPER GM, GROSS GJ, 1993a. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res 27: 832-838.
105. YAO Z, RASMUSSEN JL, HIRT JL, MEI DA, PIEPER GM, GROSS GJ, 1993b. Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J Cardiovasc Pharmacol 22: 653-663.
106. YAO Z, ELLIOTT GT, GROSS GJ, 1995. Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs. Pharmacology 51: 152-159.
107. YOSHIDA K, MAAIEH MM, SHIPLEY JB, DOLORESCO M, BERNARDO NL, QIAN Y, ELLIOTT GT, KUKREJA RC, 1996. Monophosphoryl lipid A induces pharmacologic "preconditioning" in rabbit hearts without concomitant expression of 70-kDa heart shock protein. Mol Cell Biochem 156: 1-8.
108. YOSHIDA T, ENGELMAN RM, ROUSOU JA, FLACK JE, BAROT MG, ELLIOTT GT, MAULIK N, DAS DK, 1998. Induction of iNOS expression by monophosphoryl lipid A: a pharmacological approach of ischemic preconditioning of swine hearts undergoing open heart surgery. Circulation (In press).
109. ZHAO L, KIRSCH CC, HAGEN SR, ELLIOTT GT, 1996. Preservation of global cardiac function in the rabbit following protracted ischemia/reperfusion using monophosphoryl lipid A (MLA). J Mol Cell Cardiol 28: 197-208.
110. ZHAO L, WEBER PA, SMITH JR, COMERFORD ML, ELLIOTT GT, 1997. Role of inducible nitric oxide synthase (iNOS) in pharmacological "preconditioning" with monophosphoryl lipid A. J Mol Cell Cardiol 29: 1567-1576.